SAB Biotherapeutics (SABS) Receivables - Net (2020 - 2023)
SAB Biotherapeutics (SABS) posted Receivables - Net of $364117.0 for Q2 2023, down 52.29% on a QoQ basis from $763123.0 in Q1 2023, and down 96.21% year-over-year from $9.6 million in Q2 2022.
SAB Biotherapeutics (SABS) Receivables - Net (2020 - 2023) Analysis & Trends
SAB Biotherapeutics' Receivables - Net history runs 4 years deep, the most recent figure standing at $364117.0 for Q2 2023.
- Quarterly Receivables - Net fell 96.21% year-over-year to $364117.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $364117.0 (down 96.21% YoY) and the FY2022 annual result came in at $5.6 million, down 30.64% from the prior year.
- Receivables - Net was $364117.0 for Q2 2023 at SAB Biotherapeutics, down from $763123.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $20.6 million in Q4 2020 and bottomed at $364117.0 in Q2 2023.
- A 4-year average of $8.7 million and a median of $8.8 million in 2021 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2022 — Receivables - Net plunged 30.64% — and 2023, when it slumped 96.21%.
- SAB Biotherapeutics' Receivables - Net stood at $20.6 million in 2020, then sank by 61.06% to $8.0 million in 2021, then plunged by 30.64% to $5.6 million in 2022, then sank by 93.45% to $364117.0 in 2023.
- Business Quant data shows SABS's Receivables - Net at $364117.0 in Q2 2023, $763123.0 in Q1 2023, and $5.6 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | SAB Biotherapeutics | 170.64 Mn | 170.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 364,117.00 |
| Jun 30, 2023 | 364,117.00 |
| Mar 31, 2023 | 763,123.00 |
| Mar 31, 2023 | 763,123.00 |
| Dec 31, 2022 | 5.56 Mn |
| Dec 31, 2022 | 5.56 Mn |
| Sep 30, 2022 | 12.90 Mn |
| Sep 30, 2022 | 12.90 Mn |
| Jun 30, 2022 | 9.61 Mn |
| Jun 30, 2022 | 9.61 Mn |
| Mar 31, 2022 | 11.79 Mn |
| Mar 31, 2022 | 11.79 Mn |
| Dec 31, 2021 | 8.01 Mn |
| Dec 31, 2021 | 8.01 Mn |
| Dec 31, 2020 | 20.57 Mn |
| Dec 31, 2020 | 20.57 Mn |